Stewart Murray 4
4 · NOVELION THERAPEUTICS INC. · Filed Feb 14, 2018
Insider Transaction Report
Form 4
Stewart Murray
Executive Vice President R&D
Transactions
- Award
Stock Option (Right to Buy)
2018-02-12+45,000→ 45,000 totalExercise: $4.44Exp: 2028-02-12→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The option shall vest and become exercisable in three equal annual installments on February 12, 2019, February 12, 2020, and February 12, 2021.